Author:
Chan Denise A.,Giaccia Amato J.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference137 articles.
1. Druker, B. J. Perspectives on the development of a molecularly targeted agent. Cancer Cell 1, 31–36 (2002).
2. Hellman, S. & Vokes, E. E. Advancing current treatments for cancer. Sci. Am. 275, 118–123 (1996).
3. Oliff, A., Gibbs, J. B. & McCormick, F. New molecular targets for cancer therapy. Sci. Am. 275, 144–149 (1996).
4. Hynes, N. E. & Lane, H. A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Rev. Cancer 5, 341–354 (2005).
5. Buchdunger, E. et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res. 56, 100–104 (1996).
Cited by
233 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献